NSE filing, NSE: REFRACTORY. Summary written from the filing by ALFA Finder's alert engine.
Refractory Shapes Ltd: key numbers
- Share price
- ₹38.85
- Market cap
- ₹84.69 Cr
- Revenue (annual)
- ₹57.04 Cr
- Net profit (annual)
- ₹4.79 Cr
- P/E (TTM)
- 17.7×Sector 52.1×
- Promoter holding
- 72.48%
- FII holding
- 0.40%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Refractory Shapes Ltd
All →Refractory Shapes H1 FY27 Results: Net Profit ₹1.9 Cr, Down 57.8% YoY
Refractory Shapes Ltd reported revenue from operations of ₹35.2 Cr (+2.3% YoY) and net profit of ₹1.9 Cr (-57.8% YoY) for H1 FY27.
- Key figure
- Net profit ₹1.9 Cr · -57.8% YoY
Refractory Shapes Management Change
Refractory Shapes appointed Mr. Dayashankar Krishna Shetty as Chairman & MD w.e.f. 12 Nov 2026 for five years. The existing promoter-director takes the top role, ensuring continuity.
- Execution
- 5 years
Refractory Shapes Annual General Meeting
Refractory Shapes held its EGM on November 12, 2026. Shareholders considered appointing Dayashankar Shetty as Managing Director and Chairperson, altering the Articles of Association, and approving executive remuneration.
Refractory Shapes Other Announcement
Refractory Shapes Ltd filed its Integrated Governance filing for the quarter and half year ended 30 Sep 2026. It claims exemption from the Corporate Governance Report and reported zero investor grievances.
Refractory Shapes Annual General Meeting
Refractory Shapes Limited issued an EGM notice scheduled for November 12, 2026. The meeting seeks approval for director appointments, remuneration, and Articles of Association amendments.
Refractory Shapes Management Change
Mrs. Prajna Shravan Shetty has resigned as the Managing Director and Chairperson of Refractory Shapes Limited, effective October 06, 2026, due to management reorganization.
Other other announcement announcements
All →Religare Enterprises Other Announcement
Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.
Optivalue Tek Consulting Other Announcement
Optivalue Tek filed Acuité's half-yearly monitoring report on IPO proceeds for H1 FY2026-27. No deviation from the offer objects was observed.
5Paisa Capital Other Announcement
5paisa Capital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(c). It reports routine holding figures with no new transaction or corporate event.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital issued a duplicate share certificate for 100 shares to Inder Chand Kothari L under folio 00008717. The intimation is routine share-certificate paperwork with no transaction or money involved.
Axel Polymers Other Announcement
Axel Polymers reports no deviation in utilisation of its Rs 11.18 Crore preferential issue proceeds for the quarter ended 30 September 2026. This is a routine Regulation 32 statement of deviation with a clean auditor certificate.
360 One Wam Other Announcement
360 ONE WAM disclosed PIT sales by five insiders on 12 November 2026, totalling about Rs 3.55 Crore. The sellers are designated persons, KMP and an employee's relative, with no promoter involved.
- Value
- ₹3.55 Cr